AzTrials
AzTrials

PainHYPNOPLUSNCT05092906

Contribution of Hypnosis During a Lumbar Puncture.

A study testing LP with complementary hypnoanalgesia in people with Pain, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the effect of hypnosis, as add on therapy, on patients requiring a lumbar puncture (LP) as part of their medical management. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain
What is being tested?
LP with complementary hypnoanalgesia
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteFrance
Study dates
9 Nov 2021to 13 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Required a lumbar puncture for diagnosis
  • Affiliated with social security system
  • Patient's written consent

Who cannot join

  • LP contraindication
  • History of previous LP
  • Psychiatric disorder making the realization of a hypnosis irrelevant
  • Cognitive-behavioural abilities that do not allow the completion of the study
  • Persons who are protected under the act. Person deprived of liberty by judicial decision
  • Pregnant or Breastfeeding woman

Trial locations and contacts

1 site in 1 country.

France1 site
  • Neurology department of Grenoble University Hospital

    Grenoble, Isere, 38043

Other trials in France

About this study

Official title: Randomized Controlled Study Evaluating The Contribution of a Hypnosis Intervention During a Lumbar Puncture in the Neurology Department.

The purpose of this study is to assess the effect of hypnosis, as add on therapy, on patients requiring a lumbar puncture (LP) as part of their medical management.

Read the detailed description

This study will follow the zelen's methodology randomization. It is an add-on study design.

  1. The study will be presented to patients as an assessment of their comfort during the LP. The intervention group is not presented to the patient.
  2. Patients are asked to sign the consent of the standard of care group.
  3. Randomization into two equally sized groups:
  • Intervention arm : LP with complementary hypnoanalgesia
  • Control arm : LP without complementary hypnoanalgesia
  1. Patients who have been randomized into the control group, will have LP according to the standard of care.

Patients who have been randomized into the hypnoanalgesic group will be informed about the hypnoanalgesia intervention and then asked to sign the consent of the hypnosis group.

  • if the patient accepts, he will benefit from hypnosis during LP.
  • if the patient refuses, he will re-join the control group without hypnosis.

The physicians performing LP will be the same in both groups. A phone call follow-up is scheduled on day 3 and 7 after intervention.

Conditions
Pain
Being tested
LP with complementary hypnoanalgesia, LP with standard of care
Keywords
lumbar puncture, anxiety
Medical subject headings
Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LP with complementary hypnoanalgesiaOther

    The lumbar puncture technique will be identical to that of the group standard of care. Hypnosis will be performed by a health professional trained in this practice, in addition to the standard analgesic management.

  • LP with standard of careOther

    The LP will be carried out according to the usual techniques without hypnosis.

    Standard analgesic treatments will be used (except contraindications):

    • EMLA (Lidocain+Prilocain) Cream/Patch
    • Local anesthesia with lidocain chlorhydrate monohydrate 1% injectable
    • Nitrous oxide
Study groups in NCT05092906
Study groupRoleWhat they receive
Lumbar puncture with standard of careActive comparatorNot described
Receives: Other: LP with standard of care
Lumbar puncture with hypnosis add-on therapyExperimentalNot described
Receives: Other: LP with complementary hypnoanalgesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum pain felt during LP

    The maximum pain experienced will be assessed in the immediate post procedure using a Numeric Pain Rating Scale (NPRS). The NPRS is a 10 points scale, ranging from 0 (no pain) to 10 (maximal pain).

    Measured: Immediately at the end of LP procedure

Secondary outcomes (6)
  1. Comfort felt during LP

    The comfort level felt during the LP procedure will be assessed with a Numeric Rating Scale (NRS). The NRS is a 10 points scale, ranging from 0 (total uncomfort) to 10 (maximal comfort).

    Measured: Immediately at the end of LP procedure

  2. Ratio of patients with a Numeric Pain Rating Scale (NPRS) score >= 4.

    Comparison between the two groups of the ratio of patient with a NPRS >= 4.

    Measured: Immediately at the end of LP procedure

  3. Acceptation of hypnosis

    Number and percentage of subjects randomized and analyzed in the hypnoanalgesia group and who have actually had hypnosis

    Measured: Day1

  4. State and Trait anxiety before LP

    The state and trait anxiety will be assess using the State and Trait anxiety inventory (STAI) questionnaire.

    Measured: Before randomization

  5. Assess pain at Day 3 and Day 7

    The pain level will be assess using the NPRS scale by telephonic interview.

    Measured: Three days and then seven days after the LP.

  6. Timeframe for resumption of usual activities.

    Number of days between LP and the resumption of usual activities

    Measured: Seven days after the LP.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start9 Nov 2021
  3. Primary completion13 Mar 2024
  4. Study completion13 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05092906
Sponsor's protocol ID
38RC20.357
Acronym
HYPNOPLUS
Status last verified
Jun 2024
First submitted
16 Sep 2021
Last updated
14 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing LP with complementary hypnoanalgesia in people with Pain, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum pain felt during LP (time frame: Immediately at the end of LP procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in